Although tirzepatide, by being a dual GIP and GLP-1 RA, works on both receptors to affect motility, which is reflected in common side effects like delayed gastric emptying, this case report underscores the need for close monitoring of patients treated with GLP-1 RAs - particularly tirzepatide - and focuses on the GLP-1-mediated effects of this dual GLP-1/GIP agonist, as rare but potentially life-threatening gastrointestinal complications can occur
10.1053/j.gastro.2014.08.037 21 DashS.XiaoC.MorgantiniC.LewisG
Keep containers tightly closed when not in use to prevent moisture exposure
Two products were slightly low in one fatty acid, but this is an improvement over results from ConsumerLab
Side effects that persist or worsen may indicate that a different medication or a different approach is more appropriate
Mu, Q., Kirby, J., Reilly, C